studyId: syn53604892 studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment initiative: Other fundingAgency: Other
Drop files to upload
ST8814_Par_TNO_3_trimmed_1_val_1_fastqc.html page is loading…